Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Judith

Judith Adnett, Stockton-On-Tees GB

Patent application number	Description	Published
20100016441	BIOCIDAL COMPOSITION AND METHOD - Composition and method for the inhibition of microbial growth in alkaline aqueous media requiring both rapid decontamination and long term preservation. The composition is a blend of 2,2-dibromo-3-nitrilopropionamide and 2-bromo-2-nitro-1,3-propanediol.	01-21-2010

Judith Amann-Brandt, Port-Westfalica DE

Patent application number	Description	Published
20120045543	SHELF-LIFE EXTENSION OF SOUR DOUGH BAKED GOODS - The present invention relates to an improved method for producing sour dough and baked goods having an extended shelf life, wherein biological preservatives are augmented in the dough or the baked goods by cofermenting selected lactobacilli.	02-23-2012

Judith Aronhime, Rechovot IL

Patent application number	Description	Published
20080287691	Polymorphic form of atorvastatin calcium - The present invention relates to atorvastatin calcium, a useful agent for lowering serum cholesterol levels. New atorvastatin calcium Form V, processes for preparing the new form, and pharmaceutical compositions and dosage forms containing the new form are disclosed.	11-20-2008
20090326033	Carvedilol - This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.	12-31-2009

Judith Becker, Heusweiler-Kutzhof DE

Patent application number	Description	Published
20110207183	Production Process for Fine Chemicals Using Microorganisms with Reduced Isocitrate Dehydrogenase Activity - The present invention is directed to a method utilizing a microorganism with reduced isocitrate dehydrogenase activity for the production of fine chemicals. Said fine chemicals may be amino acids, monomers for polymer synthesis, sugars, lipids, oils, fatty acids or vitamins and are preferably amino acids of the aspartate family, especially methionine or lysine, or derivatives of said amino acids, especially cadaverine. Furthermore, the present invention relates to a recombinant microorganism having a reduced isocitrate dehydrogenase activity in comparison to the initial microorganism and the use of such microorganisms in producing fine chemicals such as aspartate family amino acids and their derivatives.	08-25-2011

Judith Challinger, Santa Cruz, CA US

Patent application number	Description	Published
20090177980	SYSTEM AND METHOD FOR ENABLING USERS TO INTERACT IN A VIRTUAL SPACE - The present invention provides a highly scalable architecture for a three-dimensional graphical, multi-user, interactive virtual world system. In a preferred embodiment a plurality of users interact in the three-dimensional, computer-generated graphical space where each user executes a client process to view a virtual world from the perspective of that user. The virtual world shows avatars representing the other users who are neighbors of the user viewing the virtual word. In order that the view can be updated to reflect the motion of the remote user's avatars, motion information is transmitted to a central server process which provides positions updates to client processes for neighbors of the user at that client process. The client process also uses an environment database to determine which background objects to render as well as to limit the movement of the user's avatar.	07-09-2009
20090183089	SYSTEM AND METHOD FOR ENABLING USERS TO INTERACT IN A VIRTUAL SPACE - The present invention provides a highly scalable architecture for a three-dimensional graphical, multi-user, interactive virtual world system. In a preferred embodiment a plurality of users interact in the three-dimensional, computer-generated graphical space where each user executes a client process to view a virtual world from the perspective of that user. The virtual world shows avatars representing the other users who are neighbors of the user viewing the virtual word. In order that the view can be updated to reflect the motion of the remote user's avatars, motion information is transmitted to a central server process which provides positions updates to client processes for neighbors of the user at that client process. The client process also uses an environment database to determine which background objects to render as well as to limit the movement of the user's avatar.	07-16-2009
20110191413	SYSTEM AND METHOD FOR ENABLING USERS TO INTERACT IN A VIRTUAL SPACE - The present invention provides a highly scalable architecture for a three-dimensional graphical, multi-user, interactive virtual world system. In a preferred embodiment a plurality of users interact in the three-dimensional, computer-generated graphical space where each user executes a client process to view a virtual world from the perspective of that user. The virtual world shows avatars representing the other users who are neighbors of the user viewing the virtual word. In order that the view can be updated to reflect the motion of the remote user's avatars, motion information is transmitted to a central server process which provides positions updates to client processes for neighbors of the user at that client process. The client process also uses an environment database to determine which background objects to render as well as to limit the movement of the user's avatar.	08-04-2011
20110252341	SYSTEM AND METHOD FOR ENABLING USERS TO INTERACT IN A VIRTUAL SPACE - The present invention provides a highly scalable architecture for a three-dimensional graphical, multi-user, interactive virtual world system. In a preferred embodiment a plurality of users interact in the three-dimensional, computer-generated graphical space where each user executes a client process to view a virtual world from the perspective of that user. The virtual world shows avatars representing the other users who are neighbors of the user viewing the virtual word. In order that the view can be updated to reflect the motion of the remote user's avatars, motion information is transmitted to a central server process which provides positions updates to client processes for neighbors of the user at that client process. The client process also uses an environment database to determine which background objects to render as well as to limit the movement of the user's avatar.	10-13-2011
20110302507	SYSTEM AND METHOD FOR ENABLING USERS TO INTERACT IN A VIRTUAL SPACE - The present invention provides a highly scalable architecture for a three-dimensional graphical, multi-user, interactive virtual world system. In a preferred embodiment a plurality of users interact in the three-dimensional, computer-generated graphical space where each user executes a client process to view a virtual world from the perspective of that user. The virtual world shows avatars representing the other users who are neighbors of the user viewing the virtual word. In order that the view can be updated to reflect the motion of the remote user's avatars, motion information is transmitted to a central server process which provides positions updates to client processes for neighbors of the user at that client process. The client process also uses an environment database to determine which background objects to render as well as to limit the movement of the user's avatar.	12-08-2011

Judith Chebath, Rechovot IL

Patent application number	Description	Published
20100003751	Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns - A method of generating neural and glial cells is provided. The method comprising growing human stem cells under conditions which induce differentiation of said human stem cells into the neural and glial cells, said conditions comprising the presence of retinoic acid and an agent capable of down-regulating Bone Morphogenic Protein activity.	01-07-2010

Judith Chebath, Rehovot IL

Patent application number	Description	Published
20110274647	IL6R/IL6 Chimera for Therapy of Chemotherapy-Induced Peripheral Neuropathy - The invention relates to the use of IL-6R/IL-6 chimera in chemotherapy induced neuropathy.	11-10-2011

Judith Continelli, Glendale, AZ US

Patent application number	Description	Published
20100179913	System and Method for Facilitating the Handling of a Dispute Using Disparate Architecture - A system is disclosed for handling post transactional credit disputes in real-time via a variety of transactional environments and architectures. The system includes one or more workstations linked to a communication channel and one or more servers with at least one having capability of displaying a plurality of pre-existing dispute handling forms. A party in dispute may access the forms, choose an appropriate dispute handling form, provide data in the pre-defined requested fields on the form, and transmit the form over the communication channel to a server for processing. A server accepts a User ID and password from a user, retrieves and displays a set of dispute handling forms, receives input entered on the forms, routes the forms to a second user in dispute, and makes the forms available for viewing to the second user. The program may further index the data entered on the forms using a code-based method.	07-15-2010

Judith De Armas Kuntz, Raleigh, NC US

Patent application number	Description	Published
20100105654	SUBSTITUTED QUINAZOLINONE COMPOUNDS - A variety of small molecule, guanidine-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases when administered to subjects. The compounds have the structures VA, VB, VIIA and VIIB where the values of the variables are defined herein.	04-29-2010

Judith Diaz-Collier, Manchester, MO US

Patent application number	Description	Published
20090117124	Anti-IgE antibodies - The present invention relates to novel human antibodies specifically directed against human immunoglobulin E (anti-IgE). The present invention also relates to pharmaceutical compositions and methods for treating asthma, in particular allergic asthma, as well as other IgE-mediated disorders including allergic rhinitis and food allergies.	05-07-2009
20110064726	ANTI IgE ANTIBODIES - The present invention relates to novel human antibodies specifically directed against human immunoglobulin E (anti-IgE). The present invention also relates to pharmaceutical compositions and methods for treating asthma, in particular allergic asthma, as well as other IgE-mediated disorders including allergic rhinitis and food allergies.	03-17-2011

Judith Dubach-Powell, Oberwil CH

Patent application number	Description	Published
20090208425	TRANSMUCOSAL ADMINISTRATION OF 2,3-DIMETHOXY-5-METHYL-6-(10-HYDROXYDECYL)-1,4-BENZOQUINONE - Use of idebenone for the preparation of a medicament for transmucosal administration.	08-20-2009

Judith Emaus, Vista, CA US

Patent application number	Description	Published
20110253147	BREATHING APPARATUS - A breathing apparatus includes a supply tube configured to provide a supply of air. A first and second nasal interface each include a generally spherical member having a respective projection configured to be at least partially received within a respective nasal passage of a user, and are independently movable relative to the housing. A valve is disposed between the fluid chamber and an exhaust passage for selectively allowing air to be exhausted from the fluid chamber via the exhaust passage. A diaphragm, coupled to a bias chamber, is also coupled to the valve for moving the valve between the open position and the closed position. Bias pressure within the bias chamber is regulated, at least in part, by a loading fluid impedance and a venting fluid impedance.	10-20-2011

Judith Farrés, Girona ES

Patent application number	Description	Published
20110098993	METHODS AND SYSTEMS FOR IDENTIFYING MOLECULES OR PROCESSES OF BIOLOGICAL INTEREST BY USING KNOWLEDGE DISCOVERY IN BIOLOGICAL DATA - The present application relates to methods and systems of identifying molecules or processes of biological interest by using knowledge discovery in biological data. In particular, the present application describes new methods of creating a biological map, new methods of codifying such map, new methods of analyzing such map and new methods of identifying molecules and processes of biological interest. The present application provides methods and systems to identify new and useful direct or indirect therapeutic targets, molecular modulators, adverse events effectors, disease biomarkers, genetic biomarkers, safety-related biomarkers, diagnostic molecules, hormones, metabolites, or metabolic effectors of any type.	04-28-2011

Judith Farrés, Girona ES

Patent application number	Description	Published
20110098993	METHODS AND SYSTEMS FOR IDENTIFYING MOLECULES OR PROCESSES OF BIOLOGICAL INTEREST BY USING KNOWLEDGE DISCOVERY IN BIOLOGICAL DATA - The present application relates to methods and systems of identifying molecules or processes of biological interest by using knowledge discovery in biological data. In particular, the present application describes new methods of creating a biological map, new methods of codifying such map, new methods of analyzing such map and new methods of identifying molecules and processes of biological interest. The present application provides methods and systems to identify new and useful direct or indirect therapeutic targets, molecular modulators, adverse events effectors, disease biomarkers, genetic biomarkers, safety-related biomarkers, diagnostic molecules, hormones, metabolites, or metabolic effectors of any type.	04-28-2011

Judith Fellmann, Stafa CH

Patent application number	Description	Published
20110144644	RESORPTIVE INTRAMEDULLARY IMPLANT BETWEEN TWO BONES OR TWO BONE FRAGMENTS - The invention relates to a resorptive intramedullary implant between two bones or two bone fragments. The implant includes a single-piece body (	06-16-2011

Judith Firet, Ede NL

Patent application number	Description	Published
20080214832	Process for making asenapine - Asenapine and related trans-isomer bicyclic compounds can be obtained by reducing a compound of formula (C) to preferentially form a trans-isomer compound of formula (D), followed by subsequent ring closure to form a compound of formula (B) such as asenapine.	09-04-2008

Judith Grünauer, Hamburg DE

Patent application number	Description	Published
20120064318	TRANSPARENT BARRIER LAMINATES - A novel, transparent, non-substrate-based permeation barrier film for encapsulating electronic, more particularly optoelectronic, assemblies consists of a first polymer layer (	03-15-2012

Judith Haendeler, Gladbach DE

Patent application number	Description	Published
20100202987	PREPARATION FOR IMPROVING THE PROTECTION OF HUMAN CELLS, ESPECIALLY CELLS OF THE HUMAN SKIN, FROM THE HARMFUL INFLUENCES OF OXIDATIVE NOXAE AND UV RADIATION - The invention relates to topical preparations for improving the protection of the mitochondria of human skin cells from the deleterious influences of oxidative noxae and UV irradiation, said preparations being characterised by a content in proteins that are capable of permeating the mitochondrial membrane. The invention also relates to a corresponding cosmetic method for treating human skin.	08-12-2010

Judith Imgram, Albanusstrasse DE

Patent application number	Description	Published
20080264269	Cooking Appliance Comprising at Least One Gas Sensor Array, Sampling System for Such a Cooking Appliance, Method for Cooking Using Said Cooking Appliance and Method for Cleaning Said Cooking Appliance - A cooking appliance comprises at least one cooking compartment, at least one installation compartment, at least one gas sensor array for detecting the atmosphere within the cooking compartment, the atmosphere within the installation compartment, and/or the atmosphere surrounding the cooking appliance. The gas sensor array(s) have at least two separate, different individual sensors and/or at least one coherent sensor field including at least two different sensor segments. The cooking appliance additionally includes at least one storage unit for storing signals detected by the gas sensor array(s), at least one evaluation unit for processing the detected signals, at least one control unit for controlling cooking or cleaning processes, at least one first feed line for transporting the atmosphere from the cooking appliance to the gas sensor array(s), and at least one valve at the inlet and/or in the area of the first feed line.	10-30-2008

Judith Kelleher-Anderson, Clarksville, MD US

Patent application number	Description	Published
20110319391	METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS AND INHIBITING NEURONAL DEGENERATION - The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, and depression. This invention could also be used for research products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.	12-29-2011

Judith Kelleher-Andersson, Clarksville, MD US

Patent application number	Description	Published
20090305403	Isolation and Differentiation of Adult Hippocampal Arctic Squirrel Neural Stem Cells - Neuronal stem cell lines derived from the Arctic Ground Squirrel, methods related to culturing and maintaining a neuronal stem cell line derived from the Arctic Ground Squirrel and a culture media required to maintain and differentiate a neuronal stem cell line derived from the Arctic Ground Squirrel is disclosed. Antibodies specific for antigens expressed on a neuronal stem cell line derived from the Arctic Ground Squirrel, and products and methods related to the use of neuronal stem cell lines derived from the Arctic Ground Squirrel are also included.	12-10-2009
20100298318	METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS AND INHIBITING NEURONAL DEGENERATION USING ISOTHIAZOLOPYRIMIDINONES - The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, traumatic nerve injury, and depression. This invention is useful for resear products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.	11-25-2010

Judith Kelleher-Andersson, Columbia, MD US

Patent application number	Description	Published
20080234253	Methods and Compositons for Stimulating Neurogenesis and Inhibiting Neuronal Degeneration - The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, and depression. This invention could also be used for research products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.	09-25-2008
20100034784	USE OF FUSED NICOTINAMIDES TO PROMOTE NEUROGENESIS - The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.	02-11-2010
20110052552	COMPOSITIONS TO EFFECT NEURONAL GROWTH - Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed	03-03-2011
20110135612	COMPOSITIONS TO EFFECT NEURONAL GROWTH - Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed.	06-09-2011
20120027733	COMPOSITIONS TO EFFECT NEURONAL GROWTH - Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed.	02-02-2012

Judith Klinman, Berkeley, CA US

Patent application number	Description	Published
20090011939	Method of Inhibiting Ethylene Production in Plants - Methods of inhibiting ethylene production in a plant are provided that involve contacting a plant or plant part with an inhibitor of 1-aminocyclopropane-1-carboxylic acid oxidase (ACCO). The methods can be used to delay fruit and vegetable ripening, flower opening, or senescence of cut flowers. Also described are kits including an ACCO inhibitor and a floral preservative.	01-08-2009

Judith Lisoni, Oud-Heverlee BE

Patent application number	Description	Published
20080265237	Phase-Change Memory Cell Having Two Insulated Regions - A phase-change-memory cell is provided which comprises two insulated regions formed in a first phase-change material connected by a region formed in a second phase-change material. The crystallization temperature of the second phase-change material is below the crystallization temperature of the first phase-change material. By locally changing the material properties using a second PCM material, which switches phase at a lower temperature, a localized “hot spot” is obtained.	10-30-2008
20100001248	PHASE-CHANGE MEMORY CELL WITH A PATTERNED LAYER - A phase-change-material memory cell is provided. The cell comprises at least one patterned layer of a phase-change material, and is characterized in that this patterned layer comprises at least two regions having different resistivities. If the resistivity of the phase-change material is higher in a well-defined area with limited dimensions (“hot spot”) than outside this area, then, for a given current flow between the electrodes, advantageously more Joule heat will be generated within this area compared to the area of the phase-change material where the resistivity is lower.	01-07-2010

Judith Macmanus-Driscoll, Cambridge GB

Patent application number	Description	Published
20110136670	HIGH TEMPERATURE SUPERCONDUCTORS - Compositions are disclosed of a matrix of a high temperature superconductive oxide such as YBCO, with non-superconductive particles distributed in the matrix. The non-superconductive particles comprise at least one rare earth element (RE) and at least one of tantalum (Ta) and niobium (Nb). Of particular interest are non-superconductive particles of composition RE-Ta	06-09-2011

Judith Moreines, Edgewater, NJ US

Patent application number	Description	Published
20110223250	MULTI-VITAMIN AND MINERAL NUTRITIONAL SUPPLEMENTS - The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans.	09-15-2011

Judith Morrien, Amersfoort NL

Patent application number	Description	Published
20080301805	METHODS OF COMMUNICATING OBJECT DATA - In an embodiment, a method of communicating an object data is provided. The method comprises receiving the object data from a first medical information system at a second medical information system, checking for an authorization for a user of the second medical information system to view the object data and displaying the object data upon finding the authorization. The method further comprises de identifying the object data upon not finding the authorization for the user and displaying the de identified object data at the second medical information system.	12-04-2008

Judith Mueller, Grenoble FR

Patent application number	Description	Published
20080261375	Method of Forming a Semiconductor Device Having a Dummy Feature - A method for forming a semiconductor device includes identifying an area that comprises an active device region, wherein the area has a perimeter at a first location and at least a portion of the edge of the active device region is coincident with at least a portion of the perimeter, expanding the perimeter to a first distance away from the first location, wherein the first distance defines a first point of a dummy feature, determining a second point of the dummy feature, adding the dummy feature to a layout using the first point and the second point, and using the layout to form a layer in a semiconductor device.	10-23-2008

Judith Oprins, Utrecht NL

Patent application number	Description	Published
20090148449	Antibodies against cd38 for treatment of multiple myeloma - Isolated human monoclonal antibodies which bind to human CD38, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.	06-11-2009
20100092489	COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS - The invention relates to novel method for the treatment of cancer using a combination therapy comprising an antibody that binds CD38, a corticosteroid and a non- corticosteroid chemotherapeutic agent.	04-15-2010
20110099647	ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA - Isolated human monoclonal antibodies which bind to human CD38, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.	04-28-2011

Judith Oprins, Bunnik NL

Patent application number	Description	Published
20090076249	Antibodies against CD38 for treatment of multiple myeloma - Isolated human monoclonal antibodies which bind to human CD38, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.	03-19-2009

Judith Potashkin, Gurnee, IL US

Patent application number	Description	Published
20100196886	SCREENING, DIAGNOSING, TREATING AND PROGNOSIS OF PATHOPHYSIOLOGIC STATUS BY RNA REGULATION - A relationship between cancer and ribonucleic acid (RNA) regulation is described by determining intracellular levels of niRN A regulators. Generally, mRNA levels are decreased in cancer cells that may be a reflection of either reduced mRNA expression and/or increased mRNA degradation. miRNAs are identified that hybridize to an mRNA that are suspected to mediate intracellular mRNA steady state levels. Alternatively, ribonucleic acid binding protein (RBP) levels may also mediate intracellular mRNA steady state levels. In particular, this invention demonstrates an effective clinical management strategy for uterine cell cancers may be implemented by taking advantage of an exemplary relationship between P2X	08-05-2010

Judith Regn, Nurnberg DE

Patent application number	Description	Published
20090022275	Medical examination or intervention device - A medical examination or intervention device that includes at least one component, in particular a C-arm, that can be moved under a user's control via a manual control device, as well as a collision monitoring device embodied for ascertaining an imminent collision and/or one having already occurred, with the control device having a haptic indicating means, controlled by the collision monitoring device, for indicating an imminent component collision and/or one having already occurred.	01-22-2009
20090062638	Medical Diagostic Device Comprising an Operating Element for Controlling System Components - The invention relates to a medical diagnostic device comprising an operating element for controlling system components of the medical diagnostic device, said device comprising at least one operating lever which is embodied in such a way that it has at least one feature which is characteristic of the associated system component and is, for example, designed in such a way that it is congruent to the system component. In this way, the operating lever has a form adapted to that of the real system components or has the same form as said components.	03-05-2009

Judith Rishpon, Rechovot IL

Patent application number	Description	Published
20090061524	Enzyme-Channeling Based Electrochemical Biosensors - Low-cost, non-toxic and fast immunoassay systems (immunosensors) and uses thereof as analytical and diagnostic tools for detecting an immune response in a subject are disclosed. The systems and methods disclosed are based on recording an electrochemical signal which is generated proportionally to an enzymatic cascade reaction (enzyme-channeling) upon detecting an analyte, and therefore can be used to determine the titer level of an antibody analyte in a liquid sample such as artificial media, serum or blood both qualitatively and quantitatively, in a one-step and separation free immunoassay. Systems and methods based on recording an electrochemical signal which is generated proportionally to an enzymatic cascade reaction (enzyme-channeling) upon detecting an analyte, which utilize a non-toxic secondary substrate such as acetaminophen are also disclosed.	03-05-2009
20090232740	Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease - A method of detecting cancer cells is disclosed. The method comprises (a) contacting the cell with a substrate for an enzyme under conditions wherein the enzyme catalyzes a reaction of the cell with said substrate, so as to generate a product capable of producing an electrical signal; and (b) measuring a level of the electrical signal, wherein a difference in a level of said electrical signal compared to a predetermined threshold is indicative of a cancer cell. The method may be adapted for diagnosis, monitoring a cancer therapy, identifying agents capable of treating cancer and individually optimizing a cancer therapy.	09-17-2009

Judith Rishpon, Rehovot IL

Patent application number	Description	Published
20100231920	LIGHT-EMITTING INTRA-CAVITY INTERFEROMETRIC SENSORS - Light-emitting intra-cavity interferometric (ICI) optical sensors based on channel waveguide structures which include an internal light emitting material and a functionalized region. In some embodiments, the waveguides are made of a sol-gel which incorporates the light emitting material. In some embodiments, the waveguide structure includes an ICI resonator backbone and the ICI sensor is a laser sensor. In some embodiments, the resonator backbone has an interferometric Y-branch shape. In some embodiments, the resonator backbone has a Mach Zehnder interferometer shape. In some embodiments, an ICI laser sensor has an interferometric arrayed waveguide grating shape. In some embodiments, an ICI sensor may be remotely optically pumped and remotely read.	09-16-2010

Judith Schaefer, Liestal/bl CH

Patent application number	Description	Published
20100216254	DRUG MONITORING ASSAY - A method for obtaining at least one binding agent which binds a pharmaceutically active form of the compound with a higher specificity than a pharmaceutically inactive form of the compound is described by using special derivatives of said parent compound. The invention also pertains to the respectively created binding agents and derivatives. Furthermore, drug monitoring assays using said binding agents for monitoring pharmaceutically active forms of said parent compound are provided.	08-26-2010

Judith Scharte, Muenster DE

Patent application number	Description	Published
20110225663	METHOD FOR PRODUCING EUKARYOTIC ORGANISMS WITH ENHANCED PATHOGEN RESISTANCE AND/OR RESISTANCE TO STRESS AND EUKARYOTIC TRANSGENIC ORGANISMS WITH ENHANCED PATHOGEN RESISTANCE AND/OR RESISTANCE TO STRESS - A method for producing an eukaryotic organism having at least one of enhanced pathogen resistance and resistance to stress includes expressing in a cytosol of the eukaryotic organism a glucose-6-phosphate dehydrogenase with an increased NADPH tolerance compared to an endogenous cytosolic glucose-6-phosphate dehydrogenase and at least one of reducing, eliminating and suppressing an activity of the endogenous cytosolic glucose-6-phosphate dehydrogenase.	09-15-2011

Judith Shasek, Bend, OR US

Patent application number	Description	Published
20100033425	COMPUTER PERIPHERAL DEVICE INTERFACE FOR SIMULATING MOUSE, KEYBOARD, OR GAME CONTROLLER ACTION AND METHOD OF USE - A computer peripheral device interface includes a microprocessor and unique coding /USB functionality to enable a foot, feet, hands, body computer peripheral device to have the capability to function as each of programmable mouse, joystick, and/or keyboard. The inventive peripheral device interface can include a communications channel to support various custom peripherals to be linked from or to the platform or other computer peripheral device, i.e. platform, pad, cycle, balance apparatus.	02-11-2010

Judith Smith, Livermore, CA US

Patent application number	Description	Published
20090131328	FURIN INHIBITORS - Inhibitors for the endoprotease furin are provided for the prevention, diagnosis, treatment, and study of human and animal pathologies, which involve furin activity. These pathologies include infections caused by bacteria and virus that exploit host furin activity. These pathologies also include diseases that involve the expression of host proproteins that are processed by furin as a part of growth, development, and maintenance of the host organism including certain cancers of the head and neck.	05-21-2009

Judith Ultimo, Brockton, MA US

Patent application number	Description	Published
20090050500	Device for reminding the user when to dispose of a toothbrush - This invention discloses a device for reminding a user about when to change his toothbrush. In a first embodiment, the present invention is a storage device for four toothbrushes to be disposed of, one at a time, on a regular basis, such as every three months. The storage device has at least four compartments intended to hold one toothbrush each. As the top is rotated the next compartment is opened, thus exposing the next toothbrush in sequence. The top also rotates to show the name of the month or the date on which the toothbrush is to be disposed of, or the date on which the toothbrush was first used. In this manner, the user is reminded as to when to change the toothbrush. A second embodiment of the present invention is a molded elastic form that adds a soft grip texture to the toothbrush handle and includes a date or the name of a month and is also intended to remind the user when it is time to dispose/change his toothbrush.	02-26-2009

Judith Van Der Leij, Wagenborgen NL

Patent application number	Description	Published
20100040639	METHODS OF INDUCING IL-10 PRODUCTION - The invention provides a method of inducing IL-10 production.	02-18-2010

Judith Von Dahlen, Frankfurt/main DE

Patent application number	Description	Published
20110009809	EPILATION DEVICE - The invention the concerned with an epilation device for plucking hairs out of a user's skin having a vaporizer unit adapted to vaporize an application material. This allows for cooling the skin by applying a thin coating of application material prior to epilation as the vaporizer is arranged so as to apply the vaporized application material before an epilation head with respect to a use direction (B). Soothing the skin by applying a refreshing application material after epilation if the vaporizer is arranged so as to apply the vaporized application material behind the epilation head with respect to a use direction (B) may also be considered. In some embodiments, the application material is cooled by a cooling unit or heated by a heating unit in order to intensify a cooling or warming effect of the application material.	01-13-2011
20120022555	BODY GROOMING DEVICE COMPRISING AN ATOMIZER UNIT - The present invention is concerned with a body grooming device such as a hair removal device or a massaging device that comprises a drive, an application material supply for supplying an application material at an application material supply outlet, and an atomizer unit for atomizing the application material, which atomizer unit comprises a brush-like element having at least a bristle-like protrusion, said brush-like element being coupled to the drive so that the brush-like element is driven during an operation mode of the body grooming device such that the bristle-like protrusion repeatedly contacts the application material supply outlet of the application material supply. The special atomizer unit arrangement is simple, can be made in a cost efficient manner and is also effectively atomizing an application material, e.g. water, soap, lotion, gel etc.	01-26-2012

Judith Whittum-Hudson, Novi, MI US

Patent application number	Description	Published
20110236484	Genus-Wide Chlamydial Peptide Vaccine Antigens - Peptides generated from a random library that are bound by a monoclonal antibody to Chlamydial glycolipid exoantigen (GLXA) and thus mimic this antigen are disclosed. Peptides that correspond to antigen-binding regions of an anti-idiotypic antibody (mAb2) specific for anti-GLXA antibody (Ab1) which act as molecular mimics of GLXA are also disclosed used as immunogens to induce broadly reactive genus-specific anti-chlamydial antibodies. These peptides and immunogenic DNA encoding the mAb2-like peptides, microparticle or nanoparticle formulations and other formulations of these peptides are disclosed as are methods for immunizing subjects to obtain genus-specific anti-chlamydial antibodies and to treat or prevent	09-29-2011